Gregory T. Went
2019
In 2019, Gregory T. Went earned a total compensation of $2.7M as Former Chief Executive Officer at Adamas Pharmaceuticals, a 19% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $246,411 |
|---|---|
| Option Awards | $478,125 |
| Salary | $391,667 |
| Stock Awards | $383,063 |
| Other | $1,223,451 |
| Total | $2,722,717 |
Went received $1.2M in other compensation, accounting for 45% of the total pay in 2019.
Went also received $246.4K in non-equity incentive plan, $478.1K in option awards, $391.7K in salary and $383.1K in stock awards.
Rankings
In 2019, Gregory T. Went's compensation ranked 4,475th out of 13,971 executives tracked by ExecPay. In other words, Went earned more than 68.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,475 out of 13,971 | 68th |
Division Manufacturing | 1,663 out of 5,692 | 71st |
Major group Chemicals And Allied Products | 582 out of 2,189 | 73rd |
Industry group Drugs | 489 out of 1,875 | 74th |
Industry Pharmaceutical Preparations | 370 out of 1,387 | 73rd |
Source: SEC filing on April 23, 2020.
Went's colleagues
We found three more compensation records of executives who worked with Gregory T. Went at Adamas Pharmaceuticals in 2019.